EPS & Dividend: Sun Pharmaceutical Industries Ltd.

Fiscal Period: March 2021 2022 2023 2024 2025 2026 2027 2028
Dividend per Share 2 7.5 10 11.5 13.5 16 14.56 16.39 17.63
Rate of return 1.25% 1.09% 1.17% 0.83% 0.92% 0.87% 0.98% 1.05%
EPS 2 12.1 13.6 35.3 39.9 45.6 46.76 55.55 63.46
Distribution rate 62% 73.5% 32.6% 33.8% 35.1% 31.1% 29.5% 27.8%
Reference price 2 597.80 914.75 983.10 1,620.55 1,734.70 1,675.40 1,675.40 1,675.40
Nbr of stocks (in thousands) 2,399,335 2,399,276 2,399,276 2,399,335 2,399,335 2,399,335 - -
Announcement Date 5/27/21 5/30/22 5/26/23 5/22/24 5/22/25 - - -
1INR in Million2INR
Estimates

Past dividends: Sun Pharmaceutical Industries Ltd.

2025-07-06

Final Payment 5.5 INR

2025-02-05

Interim Payment 10.5 INR

2024-07-11

Final Payment 5 INR

2024-02-08

Interim Payment 8.5 INR

2023-07-27

Final Payment 4 INR

2023-02-07

Interim Payment 7.5 INR

2022-08-18

Final Payment 3 INR

2022-02-08

Interim Payment 7 INR

2021-08-22

Final Payment 2 INR

2021-02-08

Interim Payment 5.5 INR

2020-08-18

Final Payment 1 INR

2020-02-16

Interim Payment 3 INR

2019-08-19

Annual 2.75 INR

2018-09-16

Annual 2 INR

2017-09-17

Annual 3.5 INR

2016-09-07

Annual 1 INR

Upcoming events: Sun Pharmaceutical Industries Ltd.

2026-02-03 Q3 2026 Earnings Release (Projected)
2026-05-20 Q4 2026 Earnings Release (Projected)
2026-07-29 Q1 2027 Earnings Release (Projected)
2026-11-02 Q2 2027 Earnings Release (Projected)
More events

Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y)
0.87%0.98%35.83x5x6.61x
0.98%1.3%35.98x3.84x3.3x
1.61%1.61%14.05x1.6x1.77x
1.06%1.07%23x3.22x3.51x
0.79%0.76%19.31x3.21x3.34x
1.04%1.13%86.41x6.7x -
3.71%4%17.37x3.01x3.08x
- - - - -
3.47%3.48%15.73x1.29x1.98x
0.13%0.19%24.7x5.09x3.33x
Average 1.52% 1.61% 30.26x 3.66x 3.36x
Weighted average by Cap. 1.27% 1.39% 30.23x 3.71x 3.92x
See all sector dividends

Year-on-year evolution of the Yield

Dividend / Share (DPS) - Evolution of Analysts' Estimates

Dividend / Share (DPS) - Estimates Revisions

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

Annual Profit -